Blog

Liver Transplantation for Hepatocellular Carcinoma

hpbsurgery.co.nz

Dec 18, 2024, 12:33

Liver Transplantation for Hepatocellular Carcinoma

Erman Akkus shared on X:

“Liver Transplantation for Hepatocellular Carcinoma

Immunotherapy, local treatments and improved responses – expanding eligibility

Challenges: Defining criteria, designing trials, biomarkers and organ shortage. ”

Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy | Journal of Clinical Oncology

Authors: Christian Tibor Josef Magyar, Grainne Mary O’Kane, Laia Aceituno, Zhihao Li, Arndt Vogel, Jordi Bruix, Vincenzo Mazzaferro, and Gonzalo Sapisochin.

Liver Transplantation for Hepatocellular Carcinoma

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

More posts featuring Erman Akkus.

and Gonzalo Sapisochin. Arndt Vogel cancer Christian Tibor Josef Magyar Erman Akkus Grainne Mary O'Kane Jordi Bruix Laia Aceituno OncoDaily Oncology Vincenzo Mazzaferro Zhihao Li

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage